Two Sigma Investments, LP Passage Bio, Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Passage Bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 49,364 shares of PASG stock, worth $27,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,364

Previous 98,041 49.65%

Holding current value

$27,643

Previous $68,000 58.82%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.47 - $1.13 $22,878 - $55,005	-48,677 Reduced 49.65%	49,364 $28,000
Q3 2024 Nov 14, 2024	SELL	$0.64 - $1.0 $3,720 - $5,813	-5,813 Reduced 5.6%	98,041 $68,000
Q2 2024 Aug 14, 2024	SELL	$0.79 - $1.58 $76,866 - $153,732	-97,299 Reduced 48.37%	103,854 $82,000
Q4 2023 Feb 14, 2024	SELL	$0.6 - $1.01 $16,260 - $27,372	-27,101 Reduced 11.87%	201,153 $203,000
Q3 2023 Nov 14, 2023	SELL	$0.66 - $1.01 $20,856 - $31,916	-31,600 Reduced 12.16%	228,254 $150,000
Q2 2023 Aug 14, 2023	SELL	$0.82 - $1.19 $23,839 - $34,595	-29,072 Reduced 10.06%	259,854 $244,000
Q1 2023 May 15, 2023	SELL	$0.96 - $1.88 $62,877 - $123,134	-65,497 Reduced 18.48%	288,926 $277,000
Q4 2022 Feb 14, 2023	SELL	$1.06 - $1.48 $33,270 - $46,452	-31,387 Reduced 8.14%	354,423 $489,000
Q3 2022 Nov 14, 2022	SELL	$1.22 - $2.48 $4,498 - $9,143	-3,687 Reduced 0.95%	385,810 $482,000
Q2 2022 Aug 15, 2022	SELL	$1.63 - $3.46 $201,702 - $428,154	-123,744 Reduced 24.11%	389,497 $919,000
Q1 2022 May 16, 2022	BUY	$2.66 - $6.49 $225,145 - $549,320	84,641 Added 19.75%	513,241 $1.59 Million
Q4 2021 Feb 14, 2022	BUY	$6.24 - $10.2 $1.39 Million - $2.27 Million	222,960 Added 108.42%	428,600 $2.72 Million
Q3 2021 Nov 15, 2021	BUY	$9.73 - $15.52 $1.13 Million - $1.81 Million	116,336 Added 130.27%	205,640 $2.05 Million
Q2 2021 Aug 16, 2021	BUY	$12.44 - $19.45 $932,900 - $1.46 Million	74,992 Added 523.98%	89,304 $1.18 Million
Q1 2021 May 17, 2021	BUY	$16.24 - $29.83 $232,426 - $426,926	14,312 New	14,312 $250,000

Others Institutions Holding PASG

# of Institutions

Shares Held

37.7M

Call Options Held

10.5K

Put Options Held

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $30.5M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Passage Bio, Inc. Transaction History